[Federal Register Volume 68, Number 118 (Thursday, June 19, 2003)]
[Notices]
[Page 36844]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-15536]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 23, 2001, and April 21, 
2003, Eli-Elsohly Laboratories, Inc., Mahmoud A. Elsohly Ph.D., 5 
Industrial Park Drive, Oxford, Mississippi 38655, made application by 
renewal to the Drug Enforcement Administration (DEA) for registration 
as a bulk manufacturer of the basic classes of Schedule I and II 
controlled substances listed below:

------------------------------------------------------------------------
                            Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............................            I
Dihydromorphine (9145).....................................            I
Amphetamine (1100).........................................           II
Methamphetamine (1105).....................................           II
Cocaine (9041).............................................           II
Codeine (9050).............................................           II
Dihydrocodeine (9120)......................................           II
Oxycodone (9143)...........................................           II
Hydromorphone (9150).......................................           II
Benzoylecognine (9180).....................................           II
Hydrocodone (9193).........................................           II
Morphine (9300)............................................           II
------------------------------------------------------------------------

    The firm plans to manufacture non-deuterated controlled substances 
for use as analytical standards and deuterated controlled substances 
for use as internal standards.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCD) and must be filed no later than August 18, 2003.

    Dated: June 6, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-15536 Filed 6-18-03; 8:45 am]
BILLING CODE 4410-09-M